VABYSMO sol inj 6 mg/0.05 ml flac 0.24 ml
7680683950019
CH-68395
S01LA09
11.99.0.
Reimbursement limitations:
VABYSMO
Pour le traitement de la dégénérescence maculaire liée à l’âge exsudative (humide) (DMLA) ou d’une …
1 / 2
google
Details
- Product number
- 6839501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- faricimabum 6 mg, histidinum, acidum aceticum 30 per centum ad pH, methioninum, natrii chloridum corresp. natrium 0.028 mg, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.05 ml.
Articles (1)
Vabysmo 6 mg/0,05 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.028 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 920.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2022
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 68395
- Drug name
- Vabysmo, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- S01LA09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 25/05/2022
- Authorization expiration date
- 24/05/2027
- IT number
- 11.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VABYSMO sol inj 6 mg/0.05 ml flac 0.24 ml
- Description (DE)
- VABYSMO Inj Lös 6 mg/0.05 ml Durchstf 0.24 ml
- Market launch
- 25/05/2022
- Narcotic (BTM)
- No